Lycopene cold water dispersible products from Blakeslea trispora. EC No. 83
September 2007: Application from Vitatene, to approve Lycopene Cold Water Dispersible products from the fungus Blakeslea trispora. Authorised April 2009.
This application is essentially an extension of use as the basic ingredient (lycopene obtained from the fermentation of Blakeslea trispora) in an oil suspension form which was authorised as a novel food ingredient in 2006. The applicant proposes to market its lycopene in a cold water dispersible form for incorporation into a range of food categories including beverages, cereal and cereal products, milk and milk products, sugars, preserves and confectionery. Approval is sought under Novel Foods Regulation (EC) No. 258/97.
Before a novel food can be marketed legally in EU it requires a pre-market safety assessment under the Novel Food Regulation (EU) 2015/2283, previously 258/97 (EC). This is the Regulation establishes the legal basis for novel foods and the process for submitting a novel food authorisation(s).
One of the major changes under the revised Regulation, was the centralisation of the authorisation process at the EU level. Prior to this, applications for new novel foods were underwent initial assessment in a Member State to achieve an EU wide authorisation. This application was received by the UK under Regulation 258/97 EC and was assessed by our independent experts the Advisory Committee on novel foods and processes.
Application Status: Authorised
Before any new food product can be introduced on the European market, it must be rigorously assessed for safety. In the UK, the assessment of novel foods is carried out by an independent committee of scientists appointed by the Food Standards Agency, the Advisory Committee on Novel Foods and Processes (ACNFP). In April 2009 Vitatene was granted authorisation to market its lycopene cold water dispersible products from Blakeslea trispora) in the EU by Commission Decision 2009/365/EC.